Kyn Therapeutics Banks $49M to Advance Cancer Immunometabolism Therapies Post author:Sam Post published:December 13, 2017 Post category:BioPharma Investors were Atlas Venture and OrbiMed. Source: BioSpace You Might Also Like Concert Pharma Reports Second Quarter 2017 Financial Results And Provides Company Update August 7, 2017 2 Biotechs Insiders Just Bought $70 Million Worth of Stock In June 7, 2017 IsoRay Announces Appointment Of As Controller, Principal Accounting And Financial Officer July 6, 2017
Concert Pharma Reports Second Quarter 2017 Financial Results And Provides Company Update August 7, 2017
IsoRay Announces Appointment Of As Controller, Principal Accounting And Financial Officer July 6, 2017
